Inovio Biomedical to Present at Vaccine Global Congress

Inovio Biomedical Corp., a company engaged in DNA vaccine design, development and delivery, announced it will make multiple presentations at the Vaccine 3rd Global Congress being held in Singapore October 4th - 6th.

In a release, the Company noted event details:

Inovio representatives will be making the following presentations regarding electroporation-delivered DNA vaccines:

Delivering on the Promise of DNA Vaccines for HIV and Cancer:

From Bench to Clinical Data

David Weiner, Ph.D., Professor, University of Pennsylvania; Chairman, Scientific Advisory Board, Inovio Biomedical

Plenary Session 5, Novel Vaccines and Delivery Systems

Grand Ballroom

Monday, October 5

13:40

Development of Universal SynCon DNA Vaccines for Pandemic and Seasonal Flu

Niranjan Y. Sardesai, Ph.D., Senior VP, R & D, Inovio Biomedical

Breakout Session 1, JSV Sponsored Session and Influenza

Grand Ballroom

Monday, October 5

17:20

The presentations will include progress on programs in Inovio's pipeline. The congress program consists of invited lectures and presentations selected from submitted abstracts broadly covering vaccine development. The key objectives of the Vaccine 3rd Global Congress are to:

- provide a progressive report for scientists, governmental authorities and healthcare workers

- accelerate progress in the development of vaccines

- encourage a prophylactic approach to healthcare.

More Information:

http://www.vaccinecongress.com/.

((Comments on this story may be sent to health@closeupmedia.com))

Related terms: biomedical, cancer, clinical, congress, dna, health, healthcare, hiv, pennsylvania, pipeline, science, singapore, university, vaccine